NAD + homeostasis in human health and disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Abstract Depletion of nicotinamide adenine dinucleotide (NAD + ), a central redox cofactor and the substrate of key metabolic enzymes, is the causative factor of a number of inherited and acquired diseases in humans. Primary deficiencies of NAD + homeostasis are the result of impaired biosynthesis, while secondary deficiencies can arise due to other factors affecting NAD + homeostasis, such as increased NAD + consumption or dietary deficiency of its vitamin B3 precursors. NAD + depletion can manifest in a wide variety of pathological phenotypes, ranging from rare inherited defects, characterized by congenital malformations, retinal degeneration, and/or encephalopathy, to more common multifactorial, often age‐related, diseases. Here, we discuss NAD + biochemistry and metabolism and provide an overview of the etiology and pathological consequences of alterations of the NAD + metabolism in humans. Finally, we discuss the state of the art of the potential therapeutic implications of NAD + repletion for boosting health as well as treating rare and common diseases, and the possibilities to achieve this by means of the different NAD + ‐enhancing agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008 · cited 3×
“Sirtuins are a family of NAD+-dependent protein deacetylases that, in mammals, consists of seven members (SIRT1 to SIRT7) with different subcellular locations (Michishita et al, 2005; Houtkooper et al, 2012).”
BackgroundMethodSelf-citationBrown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Williamson, D., Lund, P., & Krebs, H. (1967) · Biochemical Journal · doi:10.1042/bj1030514 · Cited by 1,871
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · cited 2×
“Until very recently, six molecules were considered to act as extracellular NAD+ precursors including tryptophan, NA, NAM, nicotinic acid riboside (NaR), NMN, and NR (Tempel et al, 2007; Canto et al, 2015; Rajman et al, 2018).”
BackgroundYing, W. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1672 · Cited by 1,494 · cited 4×
“For more information about the implications of the NAD+:NADH balance, diseases affecting this balance, and innovative therapies in this domain, we refer the readers to several reviews dealing with this topic (Ying, 2008; Teodoro et al, 2013; Xiao et al, 2018).”
BackgroundMethodInfluentialNAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255 · cited 1×
“…NAD+-enhancing molecules was successful in ameliorating the outcomes of these conditions, including neurodegenerative disorders (Liu et al, 2013; Zhou et al, 2015; Schondorf et al, 2018), metabolic diseases (Revollo et al, 2007; Yoshino et al, 2011; Canto et al, 2012; Lee et al, 2015; Katsyuba…”
BackgroundCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238 · cited 1×
“Indian J Dermatol 53: 31 – 32 Perrault I, Hanein S, Zanlonghi X, Serre V, Nicouleau M, Defoort-Delhemmes S, Delphin N, Fares-Taie L, Gerber S, Xerri O et al (2012) Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy.”
BackgroundSelf-citationMouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210 · cited 4×
“…case of NAM, or through the equilibrative nucleoside transporters (ENTs) SLC29A1-4 in the case of NR, both molecules are directly converted into nicotinamide mononucleotide (NMN) by the enzyme NAM phosphoribosyltransferase (NAMPT) or the NR kinases (NRKs), respectively (Mouchiroud et al, 2013a).”
BackgroundSelf-citationMills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930 · cited 1×
“…disorders (Liu et al, 2013; Zhou et al, 2015; Schondorf et al, 2018), metabolic diseases (Revollo et al, 2007; Yoshino et al, 2011; Canto et al, 2012; Lee et al, 2015; Katsyuba et al, 2018), and age-related complications (Mouchiroud et al, 2013b; Mills et al, 2016; Zhang et al, 2016).”
BackgroundNampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911 · cited 3×
“…al, 2006; Camacho-Pereira et al, 2016), and (ii) compromised NAD+ biosynthesis, which is primarily caused by decreased NAMPT-mediated NAD+ salvage (Revollo et al, 2007; Yoshino et al, 2011; Liu et al, 2012; Ghosh et al, 2014), but also by a decrease in the activity of the mitochondrial enzyme…”
Background
Cited by
Mitochondria-associated programmed cell death as a therapeutic target for age-related disease
Nguyen, T. T., Wei, S., Nguyen, T. H., Jo, Y., Zhang, Y., Park, W., Gariani, K., Oh, C.-M., Kim, H. H., Ha, K.-T., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01046-5 · Cited by 325
Self-citationHuang, Y., Meng, K., Liu, G., Chen, Z., Han, Y., Yang, P., Zhang, R., & Cai, H. (2025) · Biology · doi:10.3390/biology14091167 · Cited by 7
Metadata
- Authors
- Zapata‐Pérez, R., Wanders, R. J. A., van Karnebeek, C. D. M., & Houtkooper, R. H.
- Venue
- EMBO Molecular Medicine
- Published
- 2021-05-27
- Volume
- 13
- Issue
- 7
- Pages
- e13943-e13943
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W3165186859
- Cited by
- 238
- References
- 49
- FWCI
- 16.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NAD + homeostasis in human health and disease. https://app.cochat.ai/papers/10.15252/emmm.202113943
- The paper
- Zapata‐Pérez, R., Wanders, R. J. A., van Karnebeek, C. D. M., & Houtkooper, R. H. (2021). NAD + homeostasis in human health and disease. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202113943
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.